Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mally

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Veterinary Pathology|August 6, 2013
An exploratory evaluation of the utility of transcriptional and urinary kidney injury biomarkers for the prediction of aristolochic acid-induced renal injury in male ratsT C Fuchs, A Mally, A Wool, et al.
Toxicology|March 17, 2015
Application of a discovery to targeted LC-MS proteomics approach to identify deregulated proteins associated with idiosyncratic liver toxicity in a rat model of LPS/diclofenac co-administrationS Ramm, B Morissey, B Hernandez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 20, 2021
Certain public-reported immune-mediated adverse events for PD-1 inhibitors in melanoma occur at higher rates than in clinical trialsN Gupta, C Cullison, A Mally, et al.
Toxicology|December 3, 2014
Application of RNA interference to improve mechanistic understanding of omics responses to a hepatotoxic drug in primary rat hepatocytesM Adler, E Leich, H Ellinger-Ziegelbauer, et al.
Marine Environmental Research|November 1, 2002
Different levels of mussel (Mytilus edulis) DNA strand breaks following chronic field and acute laboratory exposure to polycyclic aromatic hydrocarbonsA T Large, J P Shaw, L D Peters, et al.
Toxicologic Pathology|February 4, 2010
Evidence of oxidative stress and associated DNA damage, increased proliferative drive, and altered gene expression in rat liver produced by the cholangiocarcinogenic agent furanK C Hickling, J M Hitchcock, V Oreffo, et al.
Archives of Toxicology|December 6, 2023
Correction: Species-differences in the in vitro biotransformation of trifluoroethene (HFO-1123)R Dekant, R Bertermann, J Serban, et al.
Archives of Toxicology|October 4, 2023
Species-differences in the in vitro biotransformation of trifluoroethene (HFO-1123)R Dekant, R Bertermann, J Serban, et al.
Archives of Toxicology|April 4, 2024
Validation of putative biomarkers of furan exposure through quantitative analysis of furan metabolites in urine of F344 rats exposed to stable isotope labeled furanC Kalisch, M Reiter, M Krieger, et al.
Toxicology Letters|April 6, 2010
Assessment of candidate biomarkers of drug-induced hepatobiliary injury in preclinical toxicity studiesM Adler, D Hoffmann, H Ellinger-Ziegelbauer, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Veterinary Pathology|August 6, 2013
An exploratory evaluation of the utility of transcriptional and urinary kidney injury biomarkers for the prediction of aristolochic acid-induced renal injury in male ratsT C Fuchs, A Mally, A Wool, et al.
Toxicology|March 17, 2015
Application of a discovery to targeted LC-MS proteomics approach to identify deregulated proteins associated with idiosyncratic liver toxicity in a rat model of LPS/diclofenac co-administrationS Ramm, B Morissey, B Hernandez, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 20, 2021
Certain public-reported immune-mediated adverse events for PD-1 inhibitors in melanoma occur at higher rates than in clinical trialsN Gupta, C Cullison, A Mally, et al.
Toxicology|December 3, 2014
Application of RNA interference to improve mechanistic understanding of omics responses to a hepatotoxic drug in primary rat hepatocytesM Adler, E Leich, H Ellinger-Ziegelbauer, et al.
Marine Environmental Research|November 1, 2002
Different levels of mussel (Mytilus edulis) DNA strand breaks following chronic field and acute laboratory exposure to polycyclic aromatic hydrocarbonsA T Large, J P Shaw, L D Peters, et al.
Toxicologic Pathology|February 4, 2010
Evidence of oxidative stress and associated DNA damage, increased proliferative drive, and altered gene expression in rat liver produced by the cholangiocarcinogenic agent furanK C Hickling, J M Hitchcock, V Oreffo, et al.
Archives of Toxicology|December 6, 2023
Correction: Species-differences in the in vitro biotransformation of trifluoroethene (HFO-1123)R Dekant, R Bertermann, J Serban, et al.
Archives of Toxicology|October 4, 2023
Species-differences in the in vitro biotransformation of trifluoroethene (HFO-1123)R Dekant, R Bertermann, J Serban, et al.
Archives of Toxicology|April 4, 2024
Validation of putative biomarkers of furan exposure through quantitative analysis of furan metabolites in urine of F344 rats exposed to stable isotope labeled furanC Kalisch, M Reiter, M Krieger, et al.
Toxicology Letters|April 6, 2010
Assessment of candidate biomarkers of drug-induced hepatobiliary injury in preclinical toxicity studiesM Adler, D Hoffmann, H Ellinger-Ziegelbauer, et al.
Pageof 3